⌘K

Home/Filings/4/0001062993-22-005481

4//SEC Filing

Aklog Lishan 4

Accession 0001062993-22-005481

CIK 0001624326other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:13 PM ET

Size

5.2 KB

Accession

0001062993-22-005481

Insider Transaction Report

Form 4

Period: 2022-02-18

PAVmed Inc.PAVM

DirectorChairman and CEO

Transactions

Award
Employee stock option (right to buy)
2022-02-18+200,000→ 200,000 total
Exercise: $1.59Exp: 2032-02-18→ Common stock (200,000 underlying)

Footnotes (1)

[F1]The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

PAVmed Inc.

CIK 0001624326

Entity typeother

Related Parties

1

filerCIK 0001665074

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 8:13 PM ET
Size: 5.2 KB

View on SEC.gov